Previous studies have suggested that serum levels of adiponectin are associated with metabolic syndrome [14–19] and metabolic syndrome development may be associated with obesity, adipose tissue content, and hormonal levels. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.